US pharmaceutical firm invests $35M in Istanbul facilities
SAFURE CANTÜRK ANKARA
The U.S. pharmaceutical pioneer Amgen invested $35 million in biotech medicine in Istanbul. Amgen Global Research and Development Director Thomas Felix said Turkey's expansion in pharmaceuticals is very important.
More:US pharmaceutical firm invests $35M in Istanbul facilities - Daily Sabah
